November 26, 2015
Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Hetlioz (tasimelteon), a melatonin receptor agonist, to treat non-24- hour sleep-wake disorder ("non-24") in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorde"...



Advise patients

To take HETLIOZ before bedtime at the same time every night.

  • To skip the dose that night if they cannot take HETLIOZ at approximately the same time on a given night.
  • To limit their activities to preparing for going to bed after taking HETLIOZ because HETLIOZ can potentially impair the performance of activities requiring complete mental alertness.
  • That because of individual differences in circadian rhythms, daily use for several weeks or months may be necessary before benefit from HETLIOZ is observed.
  • To swallow the capsule whole.

Last reviewed on RxList: 12/29/2014
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Sleep Disorders

Get tips for better sleep.